Mathieu Groussin

Prof. Dr. Mathieu Groussin serves as a Professor at the Institute of Clinical Molecular Biology (IKMB) within Kiel University (CAU), Germany, and maintains strong affiliations with the University Medical Center Schleswig-Holstein (UKSH). His academic base operates from the Rosalind-Franklin-Str. 12 facility in Kiel, where he leads research initiatives in molecular biology and microbiome sciences.

His research program specializes in the genomics and functional dynamics of host-microbiome systems, with concentrated efforts on synthetic bacterial community ecology to understand and modulate Inflammatory Bowel Disease (IBD)-associated microbiomes. This interdisciplinary work bridges microbial ecology, genomic analysis, and clinical applications through synthetic biology approaches, aiming to develop novel therapeutic strategies for microbiome-related disorders.

Prof. Groussin co-leads the DFG-funded "mitarget" Phase 2 project alongside Prof. Dr. Mathilde Poyet, coordinating research across a multi-institutional consortium including Christian-Albrechts-Universität zu Kiel, Research Center Borstel – Leibniz Lung Center, Helmholtz Munich (HMGU), Max Planck Institute for Evolutionary Biology, University Medical Center Schleswig-Holstein (UKSH), and Universität zu Lübeck. His laboratory focuses on engineering bacterial communities for IBD treatment development, with active participation in research training despite no specific student names being documented in the source material.